PharmaWallah

Pharmacokinetics

Maintenance Dose Calculator

Calculates the dose per interval that keeps a drug at its target steady-state concentration, from clearance, bioavailability and the dosing interval.

Maintenance dose per interval

600.0mg every 12 h

1200.0 mg/day total · Twice daily

Inputs

mg/L

Average level at steady state. Typical: digoxin 0.8–2.0 mcg/L, vancomycin 10–20 mg/L (trough), phenytoin 10–20 mg/L.

L/h

Volume of plasma cleared of drug per hour.

%

100% for IV. Leave blank for no adjustment.

Dosing interval (τ)

q12h = every 12 hours. Frequency: Twice daily.

Try an example drug

Working

MD = (Cₛₛ × Cl × τ) ÷ F10 × 5 × 12 ÷ 1
Dose per interval600.0mg
Total daily dose1200.0mg/day
FrequencyTwice daily

Steady state

Half-life estimated as 0.693 ÷ (Cl ÷ 50 L) — a typical Vd, not this patient's.

Estimated half-life6.9h
Time to steady state (4.32 × t½)29.9h (~2 days)

Worked example: Oral maintenance dose for a target average level

A teaching exercise: Drug X is to be given by mouth every 12 hours to hold an average steady-state plasma concentration of 12 mg/L. In this (illustrative) patient its clearance is 3 L/h, its oral bioavailability is 80 % and its half-life is 8 h. Find the dose per interval, the daily dose, and how the level will behave at steady state.

Target Cₛₛ (average)
12 mg/L
Clearance (Cl)
3 L/h
Bioavailability (F)
80 % (enter 80)
Dosing interval (τ)
q12h = 12 h
Half-life (Enter half-life mode)
8 h
  1. Maintenance dose

    MD = (Cₛₛ × Cl × τ) ÷ F = (12 mg/L × 3 L/h × 12 h) ÷ 0.80 = 432 ÷ 0.80 = 540.0 mg

  2. Check the units

    mg/L × L/h × h = mg

  3. Daily dose

    540.0 mg × (24 h ÷ 12 h) = 1080.0 mg/day

  4. Rate constant

    k = 0.693 ÷ t½ = 0.693 ÷ 8 h = 0.0866 h⁻¹; k × τ = 0.0866 × 12 = 1.04

  5. Time to steady state (~95 %)

    4.32 × t½ = 4.32 × 8 h = 34.6 h (about 2 days)

  6. Accumulation ratio

    R = 1 ÷ (1 − e^(−1.04)) = 1 ÷ (1 − 0.354) = 1.55

  7. Peak/trough ratio

    e^(k × τ) = e^(1.04) = 2.83

MD = 540.0 mg every 12 h (1080.0 mg/day); steady state in ≈ 34.6 h; R = 1.55; peak/trough ≈ 2.83.

540 mg every 12 hours puts in, on average, exactly what 3 L/h of clearance removes when the mean level is 12 mg/L: 540 × 0.80 ÷ (3 × 12) = 12 mg/L. That 12 mg/L is the time-averaged level, not the peak or the trough. With a 12 h interval and an 8 h half-life the peak is about 2.8 times the trough, and steady-state levels are about 1.55 times those after the first dose. This is a teaching calculation on illustrative values: a real regimen is set by the prescriber from the drug's licensed dosing and the institution's protocol, rounded to an available strength, and confirmed by monitoring — not by this calculator.

Common mistakes

Typing F as a fraction into a percentage field. This page expects 80 for 80 %; entering 0.8 is read as 0.8 % and makes the dose 100 times too large.
Mismatching time units. Cl in L/h needs τ in hours; a clearance in mL/min must be converted first (mL/min × 60 ÷ 1000 = L/h), or the dose is out by a factor of 16.7.
Treating a trough or peak target as Cₛₛ. The formula gives the dose for the average steady-state level; a trough target (as for vancomycin) or a peak target (as for aminoglycosides) needs the intermittent-infusion equations instead.
Forgetting the salt factor. The formula gives mg of active drug; if the product is a salt (for example a hydrochloride or sodium salt), divide by the salt fraction S to get the mg of salt to give.
Expecting a bigger dose to reach steady state sooner. The time to steady state depends only on the half-life (about 4–5 half-lives); only a loading dose gets the level to target sooner.
Using Vd to work out the maintenance dose. Vd sets the loading dose and, with Cl, the half-life; the maintenance dose depends on clearance alone.

Assumptions and limitations

Assumes linear, first-order elimination: clearance is the same at every concentration. Drugs with saturable metabolism, such as phenytoin, do not follow this formula.
Assumes a one-compartment model and that clearance and F stay constant between doses; renal or hepatic change, interactions or illness alter both.
Cₛₛ is the average concentration over an interval. The accumulation and peak/trough figures treat each dose as an instantaneous (bolus-like) input and ignore absorption time.
Without an entered half-life, the page estimates t½ from Cl and an assumed Vd of 50 L for every drug, so the time to steady state shown in that mode is only a rough placeholder.
Does not round to available tablet or vial strengths and does not include a salt factor.

References

  1. Ducharme MP, Shargel L, editors. Shargel and Yu's Applied Biopharmaceutics & Pharmacokinetics. 8th ed. New York: McGraw Hill; 2022.
  2. Rowland and Tozer's Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 5th ed. Philadelphia: Wolters Kluwer; 2019.

Common questions

Prepared by the PharmaWallah student team. Verify results with your textbook or instructor. Report an error · Editorial policy